Status:
RECRUITING
Normative Database of Healthy Subject Vascular Density Using Spectralis Heidelberg® Optical Coherence Tomography Angiography
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Collaborating Sponsors:
GHPSO de Creil
Hôpital Saint Vincent de Paul, Lille
Conditions:
Optical Coherence Tomography
Optical Coherence Tomography Angiography
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Optical coherence tomography angiography (OCT-A) is a determinant progress to study retinal and choroidal vasculature without using a dye injection. OCT-A yields interesting results in different patho...
Eligibility Criteria
Inclusion
- Voluntary adult subjects or legal representative consenting for minor or subjects under protection
- Intra ocular pression ≤ 21mmHg
- Spherical refraction comprised between - 6 D and +6 D and/or axial length between 21 and 26mm
- Patient affiliated to social security system
Exclusion
- Ocular diseases: glaucoma, retinal diseases as diabetic retinopathy, age-related macular degeneration, amblyopia, optic neuropathy
- Diabetes mellitus
- Uncontrolled hypertension blood pressure (\> 140/90)
- Recent ocular surgery (\< 6 months)
- Any ophthalmological conditions interfering with a good ocular examination or OCT quality (cataract, corneal opacity …)
- OCT-A sufficient quality ≥ 25 (0 = bad quality /40 = excellent quality
- Not consenting patient
- Pathological situation or handicap avoiding good installation
Key Trial Info
Start Date :
June 12 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06043622
Start Date
June 12 2023
End Date
September 1 2026
Last Update
September 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amiens University Hospital
Amiens, France, 80054